Abstract
This cross-sectional study evaluates the use of the US Food and Drug Administration’s Real-Time Oncology Review (RTOR) program in confirming the effectiveness of cancer drugs.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have